Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-03-20 | 2026-03-20 |
| Drug Identification Number | 02543397 | 02543397 |
| Brand name | JAMP EPLERENONE | JAMP EPLERENONE |
| Common or Proper name | Eplerenone Tablets | Eplerenone Tablets |
| Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
| Ingredients | EPLERENONE | EPLERENONE |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | Carton/Blister 3x10 | Carton/Blister 3x10 |
| Additional packaging sizes | ||
| ATC code | C03DA | C03DA |
| ATC description | POTASSIUM-SPARING AGENTS | POTASSIUM-SPARING AGENTS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2026-03-12 | 2026-03-12 |
| Estimated end date | ||
| Actual end date | 2026-04-24 | 2026-04-24 |
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Allocation, manufacturer delay | Allocation, manufacturer delay |
| Health Canada comments |